Intensive follow-up strategies improve outcomes in nonmetastatic colorectal cancer patients after curative surgery: A systematic review and meta-analysis

Annals of Oncology

Volumn 26, Issue 4, 2015, Pages 644-656

  Pita Fernandez S ^a,b   Alhayek Ai M ^a   Gonzalez Martin C ^b   Lopez Calvino B ^a,b   Seoane Pillado, T ^a,b   Pertega Diaz S ^a,b  

^a HOSPITAL JUAN CANALEJO   (Spain)

^b UNIVERSITY OF A CORUÑA   (Spain)

Author keywords

Colorectal neoplasms; Curative surgery; Meta analysis; Surveillance

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

CANCER MORTALITY; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CAUSE OF DEATH; CLINICAL EXAMINATION; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL SURGERY; COMPARATIVE EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC TEST; FOLLOW UP; HUMAN; IMAGE ANALYSIS; INTENSIVE CARE; LIVER FUNCTION TEST; META ANALYSIS (TOPIC); METASTASIS POTENTIAL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTOSCOPY; REOPERATION; REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; CANCER STAGING; COLORECTAL NEOPLASMS; DIAGNOSIS; META ANALYSIS; MORTALITY; PATHOLOGY; PROGNOSIS; SURVIVAL RATE; TUMOR RECURRENCE;

COLORECTAL NEOPLASMS; FOLLOW-UP STUDIES; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; SURVIVAL RATE;

EID: 84926473205     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdu543     Document Type: Review

References (38)

1. Ferlay J, Soerjomataram I, Ervik M et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France:International Agency for Research on Cancer, 2013.
2. Böhm B, Schwenk W, Hucke HP, Stock W. Does methodic long-term follow-up affect survival after curative resection of colorectal carcinoma? Dis Colon Rectum 1993; 36: 280-286.
3. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. The pattern of recurrent colorectal cancer in a prospective randomised study and the characteristics of diagnostic tests. Int J Colorectal Dis 1997; 12: 329-334.
4. Figueredo A, Rumble RB, Maroun J et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 2003; 3: 26.
5. Johnson FE, Longo WE, Vernava AM et al. How tumor stage affects surgeons' surveillance strategies after colon cancer surgery. Cancer 1995; 76: 1325-1329.
6. Johnson FE, McKirgan LW, Coplin MA et al. Geographic variation in patient surveillance after colon cancer surgery. J Clin Oncol 1996; 14: 183-187.
7. Vernava AM, Longo WE, Virgo KS et al. Current follow-up strategies after resection of colon cancer. Results of a survey of members of the American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1994; 37: 573-583.
8. Duffy MJ, van Dalen A, Haglund C et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 2003; 39: 718-727.
9. Anthony T, Simmang C, Hyman N et al. Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 2004; 47: 807-817.
10. Törnqvist A, Ekelund G, Leandoer L. The value of intensive follow-up after curative resection for colorectal carcinoma. Br J Surg 1982; 69: 725-728.
11. Benson AB, Desch CE, Flynn PJ et al. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol 2000; 18:3586-3588.
12. Labianca R, Nordlinger B, Beretta GD et al. Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24 (Suppl 6): vi64-vi72.
13. Virgo KS, Vernava AM, Longo WE et al. Cost of patient follow-up after potentially curative colorectal cancer treatment. JAMA 1995; 273: 1837-1841.
14. Richert-Boe KE. Heterogeneity of cancer surveillance practices among medical oncologists in Washington and Oregon. Cancer 1995; 75: 2605-2612.
15. Taylor I. Quality of follow-up of the cancer patient affecting outcome. Surg Oncol Clin N Am 2000; 9: 21-25, vi.
16. Secco GB, Fardelli R, Gianquinto D et al. Efficacy and cost of risk-adapted followup in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol 2002; 28: 418-423.
17. Pietra N, Sarli L, Costi R et al. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized study. Dis Colon Rectum 1998; 41: 1127-1133.
18. Ohlsson B, Breland U, Ekberg H et al. Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up. Dis Colon Rectum 1995; 38: 619-626.
19. Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer. Results of a prospective randomized trial. Arch Surg 1995; 130: 1062-1067.
20. Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg 1997; 84:666-669.
21. Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT, and chest radiography do not influence 5-year survival of colorectal cancer patients. Gastroenterology 1998; 114: 7-14.
22. Grossmann EM, Johnson FE, Virgo KS et al. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol 2004; 13: 119-124.
23. Rodriguez-Moranta F, Salo J, Arcusa A et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol 2006; 24:386-393.
24. Wattchow DA, Weller DP, Esterman A et al. General practice vs surgical-based follow-up for patients with colon cancer: randomised controlled trial. Br J Cancer 2006; 94: 1116-1121.
25. Wang T, Cui Y, Huang W-S et al. The role of postoperative colonoscopic surveillance after radical surgery for colorectal cancer: a prospective, randomized clinical study. Gastrointest Endosc 2009; 69: 609-615.
26. Primrose JN, Perera R, Gray A et al. Effect of 3 to 5 years of scheduled CEA and CT follow-up to detect recurrence of colorectal cancer: the FACS randomized clinical trial. JAMA 2014; 311: 263-270.
27. Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for nonmetastatic colorectal cancer. Cochrane Database Syst Rev 2002; Cd002200.
28. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ 2002; 324: 813.
29. Renehan AG, Egger M, Saunders MP, O'Dwyer ST. Mechanisms of improved survival from intensive follow-up in colorectal cancer: a hypothesis. Br J Cancer 2005; 92: 430-433.
30. Tjandra JJ, Chan MK. Follow-up after curative resection of colorectal cancer: a meta-analysis. Dis Colon Rectum 2007; 50: 1783-1799.
31. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for patients treated for nonmetastatic colorectal cancer. Cochrane Database Syst Rev 2007; CD002200.
32. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986; 7:177-188.
33. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform metaanalyses of the published literature for survival endpoints. Stat Med 1998; 17:2815-2834.
34. Tierney JF, Stewart LA, Ghersi D et al. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16.
35. Williamson PR, Smith CT, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Stat Med 2002; 21: 3337-3351.
36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994; 50: 1088-1101.
37. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-634.
38. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151:264-269, W264.